IP Library Granted Patent US 10,358,411
Granted Patent B2
US 10,358,411 · App. 15/781,493 · Granted Jul 23, 2019

Method for selectively synthesizing cationic lipids

Inventors: Sungwon Choi (Daejeon, KR); Hye Yeong Nam (Seongnam-si, KR); Min-Hyo Seo (Yongin-si, KR)
Assignee: SAMYANG BIOPHARMACEUTICALS CORPORATION
C07C237/10C07C231/02C07C231/12C07C237/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,358,411
App. No.
15/781,493
Granted
Jul 23, 2019
Kind
B2
Abstract

Disclosed is a method capable of selectively synthesizing cationic lipids by controlling the introduction rate of a fatty acid group with respect to an oligoalkyleneamine by the change of reaction conditions.

Claims (43)

1. A method for preparing a cationic lipid represented by Formula 1, comprising reacting an oligoalkyleneamine represented by Formula 2, with a fatty acid alkyl ester represented by Formula 3 to prepare the cationic lipid of Formula 1:

in the formulae 1 to 3,

n and m are independently 0 to 12, with the proviso that 1≤n+m≤12,

a and b are independently 1 to 6,

one of R1 and R4 is saturated or unsaturated fatty acid group having 12 to 26 carbon atoms, and the other of R1 and R4 is hydrogen,

R2 and R3 are each independently hydrogen,

R is saturated or unsaturated hydrocarbon having 11 to 25 carbon atoms, and R5 is an alkyl group having from 1 to 14 carbon atoms,

wherein the molar ratio of the oligoalkyleneamine to the fatty acid alkyl ester is adjusted to more than 1 to 20 or less to obtain the cationic lipid of Formula 1, and wherein the oligoalkyleneamine of Formula 2 and the fatty acid alkyl ester of Formula 3 are reacted in the absence of an organic solvent.

2. A method for preparing a cationic lipid represented by Formula 1, comprising reacting an oligoalkyleneamine represented by Formula 2, with a fatty acid alkyl ester represented by Formula 3 to prepare the cationic lipid of Formula 1:

in the Formulae 1 to 3,

n and m are independently 0 to 12, with the proviso that 1≤n+m≤12,

a and b are independently 1 to 6,

R1 and R4 are each independently saturated or unsaturated fatty acid group having 12 to 26 carbon atoms,

R2 and R3 are each independently hydrogen,

R is saturated or unsaturated hydrocarbon having 11 to 25 carbon atoms, and

R5 is an alkyl group having from 1 to 14 carbon atoms,

wherein the molar ratio of the fatty acid alkyl ester to the oligoalkyleneamine is adjusted to 1 or more to 5 or less to obtain the cationic lipid of Formula 1, wherein the oligoalkyleneamine of Formula 2 and the fatty acid alkyl ester of Formula 3 are reacted in the absence of an organic solvent.

3. A method for preparing a cationic lipid represented by Formula 1, comprising reacting an oligoalkyleneamine represented by Formula 2, with a fatty acid alkyl ester represented by Formula 3 to prepare the cationic lipid of Formula 1:

in the Formulae 1 to 3,

n and m are independently 0 to 12, with the proviso that 1≤n+m≤12,

a and b are independently 1 to 6,

R1, R2, R3 and R4 are each independently saturated or unsaturated fatty acid group having 12 to 26 carbon atoms,

R is saturated or unsaturated hydrocarbon having 11 to 25 carbon atoms, and

R5 is an alkyl group having from 1 to 14 carbon atoms,

wherein the molar ratio of the fatty acid alkyl ester to the oligoalkyleneamine is adjusted to more than 5 to 20 or less to obtain the cationic lipid of Formula 1, wherein the oligoalkyleneamine of Formula 2 and the fatty acid alkyl ester of Formula 3 are reacted in the absence of an organic solvent.

4. A method for preparing a cationic lipid of Formula 1 of claim 1 where R1 and R4 are saturated or unsaturated fatty acid group having 12 to 26 carbon atoms, and one of R2 and R3 is hydrogen, wherein the method comprises

reacting the cationic lipid of Formula 1 defined in claim 3 where R1 and R4 are saturated or unsaturated fatty acid group having 12 to 26 carbon atoms and R2 and R3 are hydrogen, with a fatty acid alkyl ester of Formula 3 defined in claim 3 to prepare the cationic lipid of Formula 1 where R1 and R4 are saturated or unsaturated fatty acid group having 12 to 26 carbon atoms and one of R2 and R3 is hydrogen, wherein the molar ratio of the fatty acid alkyl ester to the cationic lipid of Formula 1 is 0.5 or more to 20 or less.

5. The method for preparing a cationic lipid according to claim 1 , wherein n and m are independently 0 to 9, with the proviso that 1≤n+m≤10.

6. The method for preparing a cationic lipid according to claim 1 , wherein n and m are independently 2 to 4.

7. The method for preparing a cationic lipid according to claim 1 , wherein the oligoalkyleneamine of Formula 2 is oligoethyleneamine.

8. The method for preparing a cationic lipid according to claim 1 , further comprising adding a nonpolar organic solvent after the reaction, precipitating and separating the cationic lipid from the unreacted materials to purify the cationic lipid.

9. The method for preparing a cationic lipid according to claim 8 , wherein the nonpolar organic solvent is an alkane or ether having 4 to 12 carbon atoms.

10. The method for preparing a cationic lipid according to claim 4 , further comprising dissolving the cationic lipid in a nonpolar organic solvent, adding an acid to separate the cationic lipid as an acid addition salt in the aqueous layer from the organic solvent, neutralizing the separated cationic lipid, and extracting and purifying the neutralized cationic lipid with a nonpolar organic solvent.

11. The method for preparing a cationic lipid according to claim 2 , wherein n and m are independently 0 to 9, with the proviso that 1≤n+m≤10.

12. The method for preparing a cationic lipid according to claim 2 , wherein n and m are independently 2 to 4.

13. The method for preparing a cationic lipid according to claim 2 , wherein the oligoalkyleneamine of Formula 2 is oligoethyleneamine.

14. The method for preparing a cationic lipid according to claim 2 , further comprising adding a nonpolar organic solvent after the reaction, precipitating and separating the cationic lipid from the unreacted materials to purify the cationic lipid.

15. The method for preparing a cationic lipid according to claim 14 , wherein the nonpolar organic solvent is an alkane or ether having 4 to 12 carbon atoms.

16. The method for preparing a cationic lipid according to claim 3 , wherein n and m are independently 0 to 9, with the proviso that 1≤n+m≤10.

17. The method for preparing a cationic lipid according to claim 3 , wherein n and m are independently 2 to 4.

18. The method for preparing a cationic lipid according to claim 3 , wherein the oligoalkyleneamine of Formula 2 is oligoethyleneamine.

19. The method for preparing a cationic lipid according to claim 3 , further comprising adding a nonpolar organic solvent after the reaction, precipitating and separating the cationic lipid from the unreacted materials to purify the cationic lipid.

20. The method for preparing a cationic lipid according to claim 19 , wherein the nonpolar organic solvent is an alkane or ether having 4 to 12 carbon atoms.

Assignments (2)
MERGER Recorded Nov 3, 2021
From: SAMYANG BIOPHARMACEUTICALS CORPORATION
To: SAMYANG HOLDINGS CORPORATION
Reel/Frame 058013/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2018
From: CHOI, SUNGWON; NAM, HYE YEONG; SEO, MIN-HYO
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 045985/0884 →
Priority Claims (1)
KR 10-2015-0189843 · Dec 30, 2015 · national
Continuity (1)
Related Publication 20180346410A1 · Dec 6, 2018